FFCP PHASE1:Mm9::chr11:65481264..65481266,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=603|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr11:65481264..65481266,+|id=chr11:65481264..65481266,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0007100!2.02e-34!18;UBERON:0000948!2.02e-34!18;UBERON:0005498!2.02e-34!18;UBERON:0004140!2.02e-34!18;UBERON:0009881!2.02e-34!18;UBERON:0004141!2.02e-34!18;UBERON:0003084!2.02e-34!18;UBERON:0007005!2.02e-34!18;UBERON:0004139!2.02e-34!18;UBERON:0004291!2.02e-34!18;UBERON:0004535!6.18e-27!23;UBERON:0001009!6.18e-27!23;UBERON:0004872!9.54e-19!33;UBERON:0003103!2.39e-14!43;UBERON:0003914!4.14e-13!47;UBERON:0003081!7.50e-07!88|ontology_enrichment_uberon_v019_2=UBERON:0007100,6.81e-11,18;UBERON:0000948,6.81e-11,18;UBERON:0005498,6.81e-11,18;UBERON:0004140,6.81e-11,18;UBERON:0009881,6.81e-11,18;UBERON:0004141,6.81e-11,18;UBERON:0003084,6.81e-11,18;UBERON:0007005,6.81e-11,18;UBERON:0004139,6.81e-11,18;UBERON:0004291,6.81e-11,18;UBERON:0004535,8.45e-09,23;UBERON:0001009,8.45e-09,23|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154267112887378,0.232533944750408,0,0.700592054203017,0,0.164167464079095,0.486412857275134,3.21639972335731,0.219550115291051,2.14730270016595,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.158167996790568,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr11:65481264..65481266,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=603 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr11:65481264..65481266,+ | |||
|description=CAGE_peak_at_chr11:65481264..65481266,+ | |||
|id=chr11:65481264..65481266,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0007100!2.02e-34!18;UBERON:0000948!2.02e-34!18;UBERON:0005498!2.02e-34!18;UBERON:0004140!2.02e-34!18;UBERON:0009881!2.02e-34!18;UBERON:0004141!2.02e-34!18;UBERON:0003084!2.02e-34!18;UBERON:0007005!2.02e-34!18;UBERON:0004139!2.02e-34!18;UBERON:0004291!2.02e-34!18;UBERON:0004535!6.18e-27!23;UBERON:0001009!6.18e-27!23;UBERON:0004872!9.54e-19!33;UBERON:0003103!2.39e-14!43;UBERON:0003914!4.14e-13!47;UBERON:0003081!7.50e-07!88 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0007100,6.81e-11,18;UBERON:0000948,6.81e-11,18;UBERON:0005498,6.81e-11,18;UBERON:0004140,6.81e-11,18;UBERON:0009881,6.81e-11,18;UBERON:0004141,6.81e-11,18;UBERON:0003084,6.81e-11,18;UBERON:0007005,6.81e-11,18;UBERON:0004139,6.81e-11,18;UBERON:0004291,6.81e-11,18;UBERON:0004535,8.45e-09,23;UBERON:0001009,8.45e-09,23 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154267112887378,0.232533944750408,0,0.700592054203017,0,0.164167464079095,0.486412857275134,3.21639972335731,0.219550115291051,2.14730270016595,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.158167996790568,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr11:65481264..65481266,+ | |||
}} |
Latest revision as of 07:45, 6 August 2015
Short description: | p@chr11:65481264..65481266, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr11:65481264..65481266, + |
Coexpression cluster: | MCL_coexpression_mm9:603 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
primary circulatory organ | 6.81e-11 | 18 |
heart | 6.81e-11 | 18 |
primitive heart tube | 6.81e-11 | 18 |
primary heart field | 6.81e-11 | 18 |
anterior lateral plate mesoderm | 6.81e-11 | 18 |
heart tube | 6.81e-11 | 18 |
heart primordium | 6.81e-11 | 18 |
cardiac mesoderm | 6.81e-11 | 18 |
cardiogenic plate | 6.81e-11 | 18 |
heart rudiment | 6.81e-11 | 18 |
cardiovascular system | 8.45e-09 | 23 |
circulatory system | 8.45e-09 | 23 |